Invo BioScience (INVO)
(Delayed Data from NSDQ)
$1.30 USD
+0.03 (2.36%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $1.28 -0.02 (-1.54%) 7:48 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INVO 1.30 +0.03(2.36%)
Will INVO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for INVO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INVO
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Misses Revenue Estimates
Clovis Oncology (CLVS) Reports Q3 Loss, Lags Revenue Estimates
INVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Regenxbio (RGNX) Reports Q3 Loss, Lags Revenue Estimates
Invo BioScience Inc. (INVO) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Invo BioScience Inc. (INVO) Upgraded to Buy: Here's What You Should Know
Other News for INVO
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers
SBFM, BPTH and INDO among pre-market losers
Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers
LI, VERU and MRIN among pre-market losers
12 Health Care Stocks Moving In Friday's Pre-Market Session